GlobeNewswire

Bombardier Wins Contract to Provide 396 MOVIA Metro Cars for Singapore's North-South and East-West Lines

Dela

Bombardier Transportation / Bombardier Wins Contract to Provide 396 MOVIA Metro Cars for Singapore's North-South and East-West Lines . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

  • New order of 396 metro cars bring the number of MOVIA vehicles in Singapore to 672, making it one of Bombardier's largest metro fleet in the world
  • The two high-capacity Mass Rapid Transit (MRT) lines total 102 km and serve 61 stations with an average daily combined ridership of 1.8 million    

BERLIN, July 26, 2018 (GLOBE NEWSWIRE) --

Note to editors: To view the photos associated with this press release, please visit the following links:

http://www.globenewswire.com/NewsRoom/AttachmentNg/d2def9e3-b8f4-4cd1-a0c7-a4ead840ba65/en http://www.globenewswire.com/NewsRoom/AttachmentNg/de1f6343-ea3b-4790-867a-07f11f62f2ee/en

Rail technology leader Bombardier Transportation today announced that it has signed a contract with Singapore's Land Transport Authority (LTA). The contract's scope covers the supply of 396 BOMBARDIER MOVIA metro cars for passenger services on the high-capacity North-South (NSL) and East-West (EWL) Mass Rapid Transit (MRT) lines. The contract is valued at approximately 827 million SGD ($607 million US, 519 million euro). The contract includes an option for long-term service support, and if exercised by SMRT Corporation Ltd, the total contract could be worth up to 1.2 billion SGD ($881 million US, 753 million euro).

Commenting on the award, Laurent Troger, President of Bombardier Transportation, said, "The proven MOVIA metro is a world leading high-performing mobility solution designed to improve public transport reliability in densely populated and fast-growing cities. For more than 20 years, Bombardier has been a strategic mobility partner to the Singapore Land Transport Authority, built on a strong track record of delivery performance, best-in-class rail technology and service excellence. Bombardier is proud to be a significant contributor to Singapore's public transport network and to support LTA's ambitious expansion plans to grow its rail network to 360 km by 2030."

The modern MOVIA metro vehicles integrate some of the world's most advanced mobility technologies including the BOMBARDIER MITRAC propulsion and control system that manages the flow of both onboard and subsystem information as well as data between the vehicle and the rail infrastructure. In its six-car configuration, the new order of 396 metro cars bring the number of MOVIA vehicles in Singapore to 672, making it one of Bombardier's largest metro fleet in the world and provide a much-needed reliability improvement on two of LTA's high-capacity lines. Combined, the two lines, running both above and underground, total 102 km in length and serve 61 stations, with an average daily combined ridership of more than 1.8 million.

Over the last 20 years in Singapore, Bombardier has delivered 276 driverless MOVIA metro cars for Singapore's Downtown Line and 13 INNOVIA APM 100 automated people mover cars for the Bukit Panjang Light Rail Transit (LRT) system. Earlier this year, a new asset replacement contract was awarded to supply 19 new INNOVIA APM 300 cars, to retrofit 13 existing APM 100 cars, as well as to deliver a signalling system upgrade for 13 stops on the Bukit Panjang LRT Line. 

About Bombardier Transportation
Bombardier Transportation is a global leader in rail technology and offers the broadest portfolio in the industry. It covers the full spectrum of rail solutions, ranging from trains to sub-systems and signalling. The company also provides complete transport systems, e-mobility technology and maintenance services. As an innovation driver, Bombardier Transportation continuously breaks new ground in sustainable mobility. It provides integrated solutions that create substantial benefits for operators, passengers and the environment. Headquartered in Berlin, Germany, Bombardier Transportation employs around 39,850 people and its products and services operate in over 60 countries.

About Bombardier
With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety.

Headquartered in Montreal, Canada, Bombardier has production and engineering sites in 28 countries across the segments of Transportation, Business Aircraft, Commercial Aircraft and Aerostructures and Engineering Services. Bombardier shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2017, Bombardier posted revenues of $16.2 billion US. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

Notes to Editors
To receive our press releases, please visit the RSS Feed section.

Bombardier, MOVIA, MITRAC and INNOVIA are trademarks of Bombardier Inc. or its subsidiaries.

For Information

Media relations, India & Southeast Asia
Harsh Mehta
+91 7838660093 
harsh.mehta@rail.bombardier.com  
Group Media Relations
+49 30 98607 1687
press@rail.bombardier.com

You can also contact one of our worldwide contacts for specific press inquiries.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bombardier Transportation via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum